(Q54431987)
Statements
Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemia. (English)
F Cavalli
L Tschopp
V E von Fliedner
C Sauter
P Maurice
A Gratwohl
M Fopp
1 March 1986
4
3
318-324